These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7044913

  • 1. Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
    Sutton DR.
    Gut; 1982 Jul; 23(7):621-4. PubMed ID: 7044913
    [Abstract] [Full Text] [Related]

  • 2. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.
    Lam SK, Lee NW, Koo J, Hui WM, Fok KH, Ng M.
    Gut; 1984 Jul; 25(7):703-6. PubMed ID: 6376292
    [Abstract] [Full Text] [Related]

  • 3. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J, Ho J, Lam SK, Wong J, Ong GB.
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [Abstract] [Full Text] [Related]

  • 4. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I, Worsley BW, O'Connor HJ, Axon AT.
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased healing of gastric and duodenal ulcers in a controlled trial using tripotassium dicitrato-bismuthate.
    Lee SP, Nicholson GI.
    Med J Aust; 1977 May 28; 1(22):808-12. PubMed ID: 329077
    [Abstract] [Full Text] [Related]

  • 9. A controlled clinical trial with De-Nol (tripotassium dicitrato bismuthate) in patients with gastric ulcer.
    Patty I, Deák G, Jávor T, Mózsik G, Nagy L, Tárnok F.
    Int J Tissue React; 1983 May 28; 5(4):397-401. PubMed ID: 6368445
    [Abstract] [Full Text] [Related]

  • 10. The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration.
    Dunk AA, Prabhu U, Tobin A, O'Morain C, Mowat NA.
    Aliment Pharmacol Ther; 1990 Apr 28; 4(2):157-62. PubMed ID: 2104081
    [Abstract] [Full Text] [Related]

  • 11. Peptic ulcer therapy with cimetidine versus tripotassium dicitrato bismuthate in rheumatoid arthritis patients undergoing chronic NSAID treatment.
    Bianchi Porro G, Lazzaroni M, Petrillo M, Ardizzone S, Manzionna G, Caruso I, Montrone F.
    Aliment Pharmacol Ther; 1998 Apr 28; 12(4):343-7. PubMed ID: 9690723
    [Abstract] [Full Text] [Related]

  • 12. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M, Lee S, Tasman-Jones C, Nicholson G.
    N Z Med J; 1985 Mar 27; 98(775):191-2. PubMed ID: 3885084
    [Abstract] [Full Text] [Related]

  • 13. Oral tripotassium-dicitratobismuthate in gastric and duodenal ulceration. A double-blind controlled trial.
    Glover SC, Cantlay JS, Weir J, Mowat NA.
    Dig Dis Sci; 1983 Jan 27; 28(1):13-7. PubMed ID: 6185289
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer.
    Chearanai O, Kachintorn U, Plengvanit U.
    J Med Assoc Thai; 1987 Apr 27; 70(4):176-80. PubMed ID: 3612003
    [No Abstract] [Full Text] [Related]

  • 15. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
    Gibiński K, Nowak A, Marlicz K, Depczyńska A, Dzieniszewski J, Milewski B, Gabryelewicz A, Kosidło S.
    Pol Tyg Lek; 1984 Nov 19; 39(47):1547-50. PubMed ID: 6393096
    [No Abstract] [Full Text] [Related]

  • 16. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
    Bergoz R.
    Schweiz Med Wochenschr; 1985 Jul 20; 115(29):1024-5. PubMed ID: 4048901
    [Abstract] [Full Text] [Related]

  • 17. Tripotassium dicitrate bismuthate and ranitidine in duodenal ulcer. Healing and influence on recurrence.
    Bianchi Porro G, Lazzaroni M, Barbara L, Corinaldesi R, Dal Monte PR, D'Imperio N, Mazzacca G, D'Arienzo A, Cheli R, Bovero E.
    Scand J Gastroenterol; 1988 Dec 20; 23(10):1232-6. PubMed ID: 3074457
    [Abstract] [Full Text] [Related]

  • 18. Twice daily tripotassium dicitrato bismuthate in the treatment of duodenal ulceration.
    Hollanders D.
    Postgrad Med J; 1986 Jan 20; 62(723):19-21. PubMed ID: 3540918
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R, Campbell CJ, Clayton NM, Clitherow JW, Grinham CJ, McColm AA, McLaren A, Trevethick MA.
    Aliment Pharmacol Ther; 1993 Jun 20; 7(3):237-46. PubMed ID: 8364129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.